Search Results - "Marton, Eva"
-
1
Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients
Published in International journal of molecular sciences (13-09-2019)“…Ovarian cancer is one of the most common cancer types in women characterized by a high mortality rate due to lack of early diagnosis. Circulating miRNAs…”
Get full text
Journal Article -
2
The Cell-Free Expression of MiR200 Family Members Correlates with Estrogen Sensitivity in Human Epithelial Ovarian Cells
Published in International journal of molecular sciences (20-12-2020)“…Exposure to physiological estrogens or xenoestrogens (e.g., zearalenone or bisphenol A) increases the risk for cancer. However, little information is available…”
Get full text
Journal Article -
3
Detection of cell-free, exosomal and whole blood mitochondrial DNA copy number in plasma or whole blood of patients with serous epithelial ovarian cancer
Published in Journal of biotechnology (10-06-2019)“…•DDetermination of mitochondrial DNA copy number in serous ovarian cancer patients and healthy controls.The first study on cell-free mtDNA copy number in…”
Get full text
Journal Article -
4
Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer
Published in Journal of biotechnology (20-05-2019)“…•Circulating miRNAs are reliable biomarkers in various cancers.•We studied their application in ovarian cancer.•MiR200 s, miR34b and miR203a proved to be…”
Get full text
Journal Article -
5
Comparative Analysis of Transcriptomic Changes including mRNA and microRNA Expression Induced by the Xenoestrogens Zearalenone and Bisphenol A in Human Ovarian Cells
Published in Toxins (01-02-2023)“…Xenoestrogens are natural or synthetic compounds that mimic the effect of endogenous estrogens and might cause cancer. We aimed to compare the global…”
Get full text
Journal Article -
6
Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients
Published in Journal of biotechnology (10-06-2019)“…•Determination of CD24 expression in cell-free plasma, exosomes and ovarian cancer tissue samples.•CD24 is overexpressed in serous epithelial ovarian…”
Get full text
Journal Article -
7
Suppressing the PI3K/AKT Pathway by miR-30d-5p Mimic Sensitizes Ovarian Cancer Cells to Cell Death Induced by High-Dose Estrogen
Published in Biomedicines (24-08-2022)“…MicroRNAs are short non-coding RNA molecules that are involved in tumor development and are considered to be promising candidates in cancer therapy. Here, we…”
Get full text
Journal Article -
8
Comparative Analysis of Cell-Free miR-205-5p, let-7f-5p, and miR-483-5p Expression in Ovarian Cell Cultures and Plasma Samples of Patients with Ovarian Cancer
Published in Applied sciences (01-02-2021)“…The term liquid biopsy reveals a non-invasive diagnostic method that might be based on the quantification of cell-free microRNAs in body fluids. However, the…”
Get full text
Journal Article -
9
Mutation in afsR Leads to A-Factor Deficiency in Streptomyces griseus B2682
Published in Journal of molecular microbiology and biotechnology (01-01-2018)“…A-factor, a γ-butyrolactone autoregulator, in Streptomyces griseus is involved in the regulation of differentiation and antibiotic production. Here we studied…”
Get more information
Journal Article -
10
Treatment outcome of immune thrombocytopenia
Published in Orvosi hetilap (14-10-2012)“…Treatment of immune thrombocytopenia is sometimes difficult and needs personal setting. According to evidence-based guidelines, corticosteroids are suggested…”
Get more information
Journal Article -
11
Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application
Published in International journal of molecular sciences (17-09-2020)“…Liquid biopsy recently became a very promising diagnostic method that has several advantages over conventional invasive methods. Liquid biopsy may serve as a…”
Get full text
Journal Article -
12
Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia
Published in Orvosi hetilap (06-11-2011)“…In Philadelphia chromosome-negative chronic myeloproliferative neoplasia, i.e. polycythemia vera, essential thrombocythemia and primary idiopathic…”
Get more information
Journal Article -
13
Treatment outcome in primary testicular non-Hodgkin lymphoma
Published in Orvosi hetilap (20-10-2013)“…Primary testicular lymphoma constitutes a rare subgroup among extranodal non-Hodgkin's lymphomas. Because of its aggressive clinical behaviour due to high…”
Get more information
Journal Article -
14
Therapeutic management of central nervous system lymphomas in a single hematological institute
Published in Orvosi hetilap (18-10-2009)“…Primary central nervous system lymphoma is defined as an extranodal lymphoma arising in the central nervous system in the absence of systemic disease. Because…”
Get more information
Journal Article -
15
Treatment outcome of patients with essential thrombocythemia at our department in Hungary
Published in Orvosi hetilap (28-02-2016)“…Essential thrombocythemia is a Philadelphia chromosome-negative chronic myeloproliferative neoplasia with a risk of bleeding and thromboembolic complications…”
Get more information
Journal Article -
16
Complex analysis of prognostic factors in chronic lymphocytic leukemia
Published in Orvosi hetilap (22-04-2007)“…Many new prognostic factors established in recent years in chronic lymphocytic leukemia. May help predicting survival. The goal of the present study was to…”
Get more information
Journal Article -
17
Absence of microdeletions in the azoospermia-factor region of the Y-chromosome in Viennese men seeking assisted reproduction
Published in Wiener Klinische Wochenschrift (15-12-2003)“…The azoospermia-factor region of the Y-chromosome is essential for spermatogenesis in humans. In the literature, a wide range is given for the frequency of…”
Get full text
Journal Article -
18
Phenotypic and genotypic analyses of blastic cell population suggest that pure B-lymphoblastic leukemia may arise from myelodysplastic syndrome
Published in Leukemia research (1998)“…The case history of a 70-year-old man with myelodysplastic syndrome terminated into acute leukemia in 22 months is presented. The leukemic cells exhibited…”
Get full text
Journal Article